Genetic aspects of non-alcoholic fatty liver disease development

Progression of non-alcoholic fatty liver disease (NAFLD) is conditioned by genetic susceptibility, environmental factors, lifestyle and features of the metabolic syndrome, many of which overlap with hepatocellular carcinoma. However, the multifactorial nature of NAFLD and the limited number of suffi...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Akhmedov, T. I. Melikov
Format: Article
Language:Russian
Published: Open Systems Publication 2021-06-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849345206793535488
author V. A. Akhmedov
T. I. Melikov
author_facet V. A. Akhmedov
T. I. Melikov
author_sort V. A. Akhmedov
collection DOAJ
description Progression of non-alcoholic fatty liver disease (NAFLD) is conditioned by genetic susceptibility, environmental factors, lifestyle and features of the metabolic syndrome, many of which overlap with hepatocellular carcinoma. However, the multifactorial nature of NAFLD and the limited number of sufficiently powerful studies are among the current limitations for validated biomarkers of clinical utility. Further studies incorporating the links between circadian regulation and hepatic metabolism may represent an additional direction in the search for predictive biomarkers of liver disease progression and treatment outcomes.
format Article
id doaj-art-ff7887c043284849aa920439bfe912b6
institution Kabale University
issn 1560-5175
2687-1181
language Russian
publishDate 2021-06-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-ff7887c043284849aa920439bfe912b62025-08-20T03:42:31ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-06-0108315Genetic aspects of non-alcoholic fatty liver disease developmentV. A. Akhmedov0T. I. Melikov1ФГБОУ ВО ОмГМУ МЗ РФФГБОУ ВО ОмГМУ МЗ РФProgression of non-alcoholic fatty liver disease (NAFLD) is conditioned by genetic susceptibility, environmental factors, lifestyle and features of the metabolic syndrome, many of which overlap with hepatocellular carcinoma. However, the multifactorial nature of NAFLD and the limited number of sufficiently powerful studies are among the current limitations for validated biomarkers of clinical utility. Further studies incorporating the links between circadian regulation and hepatic metabolism may represent an additional direction in the search for predictive biomarkers of liver disease progression and treatment outcomes.https://journal.lvrach.ru/jour/article/view/316non-alcoholic fatty liver diseasenon-alcoholic steatohepatitishepatocellular carcinomametabolic syndromegenomegwas
spellingShingle V. A. Akhmedov
T. I. Melikov
Genetic aspects of non-alcoholic fatty liver disease development
Лечащий Врач
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
hepatocellular carcinoma
metabolic syndrome
genome
gwas
title Genetic aspects of non-alcoholic fatty liver disease development
title_full Genetic aspects of non-alcoholic fatty liver disease development
title_fullStr Genetic aspects of non-alcoholic fatty liver disease development
title_full_unstemmed Genetic aspects of non-alcoholic fatty liver disease development
title_short Genetic aspects of non-alcoholic fatty liver disease development
title_sort genetic aspects of non alcoholic fatty liver disease development
topic non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
hepatocellular carcinoma
metabolic syndrome
genome
gwas
url https://journal.lvrach.ru/jour/article/view/316
work_keys_str_mv AT vaakhmedov geneticaspectsofnonalcoholicfattyliverdiseasedevelopment
AT timelikov geneticaspectsofnonalcoholicfattyliverdiseasedevelopment